Literature DB >> 32049046

Direct Phosphorylation and Stabilization of MYC by Aurora B Kinase Promote T-cell Leukemogenesis.

Jue Jiang1, Jingchao Wang1, Ming Yue2, Xiaolian Cai3, Tianci Wang4, Chao Wu4, Hexiu Su4, Yanwu Wang5, Meng Han6, Yingchi Zhang7, Xiaofan Zhu7, Peng Jiang8, Peng Li9, Yonghua Sun10, Wuhan Xiao3, Hui Feng10, Guoliang Qing1, Hudan Liu11.   

Abstract

Deregulation of MYC plays an essential role in T cell acute lymphoblastic leukemia (T-ALL), yet the mechanisms underlying its deregulation remain elusive. Herein, we identify a molecular mechanism responsible for reciprocal activation between Aurora B kinase (AURKB) and MYC. AURKB directly phosphorylates MYC at serine 67, counteracting GSK3β-directed threonine 58 phosphorylation and subsequent FBXW7-mediated proteasomal degradation. Stabilized MYC, in concert with T cell acute lymphoblastic leukemia 1 (TAL1), directly activates AURKB transcription, constituting a positive feedforward loop that reinforces MYC-regulated oncogenic programs. Therefore, inhibitors of AURKB induce prominent MYC degradation concomitant with robust leukemia cell death. These findings reveal an AURKB-MYC regulatory circuit that underlies T cell leukemogenesis, and provide a rationale for therapeutic targeting of oncogenic MYC via AURKB inhibition.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Aurora B kinase; FBXW7; MYC; T-ALL; patient-derived xenograft; phosphorylation; protein stability; zebrafish T-ALL model

Mesh:

Substances:

Year:  2020        PMID: 32049046      PMCID: PMC7321798          DOI: 10.1016/j.ccell.2020.01.001

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  60 in total

1.  Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability.

Authors:  R Sears; F Nuckolls; E Haura; Y Taya; K Tamai; J R Nevins
Journal:  Genes Dev       Date:  2000-10-01       Impact factor: 11.361

2.  Getting at MYC through RAS.

Authors:  Pavan Bachireddy; Pavan K Bendapudi; Dean W Felsher
Journal:  Clin Cancer Res       Date:  2005-06-15       Impact factor: 12.531

3.  Cell-cycle-regulated activation of Akt kinase by phosphorylation at its carboxyl terminus.

Authors:  Pengda Liu; Michael Begley; Wojciech Michowski; Hiroyuki Inuzuka; Miriam Ginzberg; Daming Gao; Peiling Tsou; Wenjian Gan; Antonella Papa; Byeong Mo Kim; Lixin Wan; Amrik Singh; Bo Zhai; Min Yuan; Zhiwei Wang; Steven P Gygi; Tae Ho Lee; Kun-Ping Lu; Alex Toker; Pier Paolo Pandolfi; John M Asara; Marc W Kirschner; Piotr Sicinski; Lewis Cantley; Wenyi Wei
Journal:  Nature       Date:  2014-03-09       Impact factor: 49.962

4.  Polo-like kinase-activating kinases: Aurora A, Aurora B and what else?

Authors:  Vincent Archambault; Mar Carmena
Journal:  Cell Cycle       Date:  2012-04-15       Impact factor: 4.534

5.  Aurora-B mediated ATM serine 1403 phosphorylation is required for mitotic ATM activation and the spindle checkpoint.

Authors:  Chunying Yang; Xi Tang; Xiaojing Guo; Yohei Niikura; Katsumi Kitagawa; Kemi Cui; Stephen T C Wong; Li Fu; Bo Xu
Journal:  Mol Cell       Date:  2011-11-18       Impact factor: 17.970

6.  Posttranscriptional deregulation of MYC via PTEN constitutes a major alternative pathway of MYC activation in T-cell acute lymphoblastic leukemia.

Authors:  Mélanie Bonnet; Marie Loosveld; Bertrand Montpellier; Jean-Marc Navarro; Benoit Quilichini; Christophe Picard; Julie Di Cristofaro; Claude Bagnis; Chantal Fossat; Lucie Hernandez; Emilie Mamessier; Sandrine Roulland; Ester Morgado; Christine Formisano-Tréziny; Willem A Dik; Anton W Langerak; Thomas Prebet; Norbert Vey; Gérard Michel; Jean Gabert; Jean Soulier; Elizabeth A Macintyre; Vahid Asnafi; Dominique Payet-Bornet; Bertrand Nadel
Journal:  Blood       Date:  2011-04-28       Impact factor: 22.113

7.  Phosphorylation by glycogen synthase kinase-3 controls c-myc proteolysis and subnuclear localization.

Authors:  Mark A Gregory; Ying Qi; Stephen R Hann
Journal:  J Biol Chem       Date:  2003-10-16       Impact factor: 5.157

8.  The Fbw7 tumor suppressor regulates glycogen synthase kinase 3 phosphorylation-dependent c-Myc protein degradation.

Authors:  Markus Welcker; Amir Orian; Jianping Jin; Jonathan E Grim; Jonathan A Grim; J Wade Harper; Robert N Eisenman; Bruce E Clurman
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-18       Impact factor: 11.205

9.  Structural basis of N-Myc binding by Aurora-A and its destabilization by kinase inhibitors.

Authors:  Mark W Richards; Selena G Burgess; Evon Poon; Anne Carstensen; Martin Eilers; Louis Chesler; Richard Bayliss
Journal:  Proc Natl Acad Sci U S A       Date:  2016-11-11       Impact factor: 11.205

10.  Long-range enhancer activity determines Myc sensitivity to Notch inhibitors in T cell leukemia.

Authors:  Yumi Yashiro-Ohtani; Hongfang Wang; Chongzhi Zang; Kelly L Arnett; Will Bailis; Yugong Ho; Birgit Knoechel; Claudia Lanauze; Lumena Louis; Katherine S Forsyth; Sujun Chen; Yoonjie Chung; Jonathan Schug; Gerd A Blobel; Stephen A Liebhaber; Bradley E Bernstein; Stephen C Blacklow; Xiaole Shirley Liu; Jon C Aster; Warren S Pear
Journal:  Proc Natl Acad Sci U S A       Date:  2014-11-04       Impact factor: 11.205

View more
  21 in total

Review 1.  T-cell Acute Lymphoblastic Leukemia: A Roadmap to Targeted Therapies.

Authors:  Valentina Cordo'; Jordy C G van der Zwet; Kirsten Canté-Barrett; Rob Pieters; Jules P P Meijerink
Journal:  Blood Cancer Discov       Date:  2020-11-24

2.  Growth arrest-specific protein 2 (GAS2) interacts with CXCR4 to promote T-cell leukemogenesis partially via c-MYC.

Authors:  Wenjuan Ma; Yan Wan; Jianxiang Zhang; Jianan Yao; Yifei Wang; Jinchang Lu; Hong Liu; Xiaorui Huang; Xiuyan Zhang; Haixia Zhou; Yulong He; Depei Wu; Jianrong Wang; Yun Zhao
Journal:  Mol Oncol       Date:  2022-09-11       Impact factor: 7.449

3.  EZH2 noncanonically binds cMyc and p300 through a cryptic transactivation domain to mediate gene activation and promote oncogenesis.

Authors:  Jun Wang; Xufen Yu; Weida Gong; Xijuan Liu; Kwang-Su Park; Anqi Ma; Yi-Hsuan Tsai; Yudao Shen; Takashi Onikubo; Wen-Chieh Pi; David F Allison; Jing Liu; Wei-Yi Chen; Ling Cai; Robert G Roeder; Jian Jin; Gang Greg Wang
Journal:  Nat Cell Biol       Date:  2022-02-24       Impact factor: 28.213

4.  Chidamide inhibits the NOTCH1-MYC signaling axis in T-cell acute lymphoblastic leukemia.

Authors:  Mengping Xi; Shanshan Guo; Caicike Bayin; Sophie Rousseaux; Saadi Khochbin; Jian-Qing Mi; Jin Wang; Lijun Peng; Florent Chuffart; Ekaterina Bourova-Flin
Journal:  Front Med       Date:  2021-10-20       Impact factor: 9.927

Review 5.  Aurora B kinase: a potential drug target for cancer therapy.

Authors:  Azaj Ahmed; Anas Shamsi; Taj Mohammad; Gulam Mustafa Hasan; Asimul Islam; Md Imtaiyaz Hassan
Journal:  J Cancer Res Clin Oncol       Date:  2021-05-28       Impact factor: 4.553

6.  USP29 coordinates MYC and HIF1α stabilization to promote tumor metabolism and progression.

Authors:  Rongfu Tu; Wenqian Kang; Mengjie Yang; Liyuan Wang; Qing Bao; Zhi Chen; Yang Dong; Jingchao Wang; Jue Jiang; Hudan Liu; Guoliang Qing
Journal:  Oncogene       Date:  2021-10-02       Impact factor: 9.867

Review 7.  Development of synthetic lethality in cancer: molecular and cellular classification.

Authors:  Shijie Li; Win Topatana; Sarun Juengpanich; Jiasheng Cao; Jiahao Hu; Bin Zhang; Diana Ma; Xiujun Cai; Mingyu Chen
Journal:  Signal Transduct Target Ther       Date:  2020-10-19

8.  The inflammatory kinase IKKα phosphorylates and stabilizes c-Myc and enhances its activity.

Authors:  Bernhard Moser; Bernhard Hochreiter; José Basílio; Viola Gleitsmann; Anja Panhuber; Alan Pardo-Garcia; Bastian Hoesel; Manuel Salzmann; Ulrike Resch; Mamoona Noreen; Johannes A Schmid
Journal:  Mol Cancer       Date:  2021-01-18       Impact factor: 27.401

Review 9.  MicroRNA as a Prognostic and Diagnostic Marker in T-Cell Acute Lymphoblastic Leukemia.

Authors:  Katarzyna Gębarowska; Anna Mroczek; Jerzy R Kowalczyk; Monika Lejman
Journal:  Int J Mol Sci       Date:  2021-05-18       Impact factor: 5.923

Review 10.  Regulation of cancer cell metabolism: oncogenic MYC in the driver's seat.

Authors:  Yang Dong; Rongfu Tu; Hudan Liu; Guoliang Qing
Journal:  Signal Transduct Target Ther       Date:  2020-07-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.